Prostate Cancer - Results from #560

Prostate cancer in transgender women: A propensity score-matched analysis of disease severity and survival. July 24, 2024

Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus. July 24, 2024

Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional Study. July 24, 2024

Survival Patterns Based on First-site-specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same? July 24, 2024

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis. July 24, 2024

Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial. July 23, 2024

Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy. July 23, 2024

Real-world evidence of 18F-fluciclovine Positron emission tomography/computed tomography performance for recurrent prostate cancer in the Veterans Affairs Health System. July 23, 2024

The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials. July 23, 2024

Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer Patients. July 23, 2024

A 2-year prospective evaluation of the Prostate Health Index in guiding biopsy decisions in a large cohort. July 23, 2024

Prostate Cancer Awareness in the Middle East: A Cross-Sectional International Study. July 23, 2024

Targeting androgen receptor degradation with PROTACs from bench to bedside. July 22, 2024

Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer. July 22, 2024

Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer. July 22, 2024

61Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. July 22, 2024

Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer. July 22, 2024

PSA, an outdated biomarker for prostate cancer: in search of a more specific biomarker, citrate takes the spotlight. July 22, 2024

Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer. July 22, 2024

Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized ControlledTrial. July 22, 2024

Page 29 of 1437